Parkinson's Disease (Central Nervous System) - Drugs in Development, 2021

Parkinson's Disease (Central Nervous System) - Drugs in Development, 2021

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Parkinson's Disease - Drugs In Development, 2021, provides an overview of the Parkinson's Disease (Central Nervous System) pipeline landscape.Parkinson's disease (PD) is a neurodegenerative disorder characterized by movement dysfunctions. The main finding in brains of people with PD is loss of dopaminergic neurons in substantia nigra. Symptoms generally develop slowly over years. People with PD experience dyskinesia, dystonia, tremor, stiffness and impaired locomotory functions. Risk factors include age, genetic factors, environmental factors and gender. Treatment options include anticholinergics, COMT inhibitors and dopamine agonists.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Parkinson's Disease - Drugs In Development, 2021, provides comprehensive information on the therapeutics under development for Parkinson's Disease (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.The Parkinson's Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Parkinson's Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 1, 10, 55, 85, 5, 254, 133 and 8 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Phase I, Preclinical and Discovery stages comprises 1, 1, 1, 55 and 18 molecules, respectively.

Parkinson's Disease (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Parkinson's Disease (Central Nervous System).
  • The pipeline guide reviews pipeline therapeutics for Parkinson's Disease (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Parkinson's Disease (Central Nervous System) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Parkinson's Disease (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Parkinson's Disease (Central Nervous System)
Reasons to Buy
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Parkinson's Disease (Central Nervous System).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Parkinson's Disease (Central Nervous System) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.


Introduction
Parkinson's Disease - Overview
Parkinson's Disease - Therapeutics Development
Parkinson's Disease - Therapeutics Assessment
Parkinson's Disease - Companies Involved in Therapeutics Development
Parkinson's Disease - Drug Profiles
Parkinson's Disease - Dormant Projects
Parkinson's Disease - Discontinued Products
Parkinson's Disease - Product Development Milestones
Appendix
List of Tables
Number of Products under Development for Parkinson's Disease, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Parkinson's Disease - Pipeline by 1st Bio Therapeutics Inc, 2021
Parkinson's Disease - Pipeline by 3Z ehf, 2021
Parkinson's Disease - Pipeline by 4D Pharma Plc, 2021
Parkinson's Disease - Pipeline by Abaxy Sprl, 2021
Parkinson's Disease - Pipeline by AbbVie Inc, 2021
Parkinson's Disease - Pipeline by Abfero Pharmaceuticals Inc, 2021
Parkinson's Disease - Pipeline by Abivax SA, 2021
Parkinson's Disease - Pipeline by ABL Bio Inc, 2021
Parkinson's Disease - Pipeline by AC Immune SA, 2021
Parkinson's Disease - Pipeline by Accure Therapeutics SL, 2021
Parkinson's Disease - Pipeline by Acelot Inc, 2021
Parkinson's Disease - Pipeline by Addex Therapeutics Ltd, 2021
Parkinson's Disease - Pipeline by Adicet Bio Inc, 2021
Parkinson's Disease - Pipeline by Affamed Therapeutics HK Ltd, 2021
Parkinson's Disease - Pipeline by AFFiRiS AG, 2021
Parkinson's Disease - Pipeline by AgoneX Biopharmaceuticals Inc, 2021
Parkinson's Disease - Pipeline by Akome Biotech Ltd, 2021
Parkinson's Disease - Pipeline by Alan Laboratories Inc, 2021
Parkinson's Disease - Pipeline by Alar Pharmaceuticals Inc, 2021
Parkinson's Disease - Pipeline by Alector Inc, 2021
Parkinson's Disease - Pipeline by Alectos Therapeutics, 2021
Parkinson's Disease - Pipeline by Alexza Pharmaceuticals Inc, 2021
Parkinson's Disease - Pipeline by Alkahest Inc, 2021
Parkinson's Disease - Pipeline by Alkermes Plc, 2021
Parkinson's Disease - Pipeline by AlphaCognition Inc, 2021
Parkinson's Disease - Pipeline by Alsonex Pty Ltd, 2021
Parkinson's Disease - Pipeline by Alterity Therapeutics Ltd, 2021
Parkinson's Disease - Pipeline by AlzeCure Pharma AB, 2021
Parkinson's Disease - Pipeline by Amathus Therapeutics Inc, 2021
Parkinson's Disease - Pipeline by Amneal Pharmaceuticals Inc, 2021
Parkinson's Disease - Pipeline by Anavex Life Sciences Corp, 2021
Parkinson's Disease - Pipeline by Annovis Bio Inc, 2021
Parkinson's Disease - Pipeline by Antoxis Ltd, 2021
Parkinson's Disease - Pipeline by Aoxing Pharmaceutical Company Inc, 2021
Parkinson's Disease - Pipeline by Appello Pharmaceuticals Inc, 2021
Parkinson's Disease - Pipeline by Aprinoia Therapeutics Inc, 2021
Parkinson's Disease - Pipeline by AptaBio Therapeutics Inc, 2021
Parkinson's Disease - Pipeline by Aptamer Sciences Inc, 2021
Parkinson's Disease - Pipeline by Aranda Pharma Ltd, 2021
Parkinson's Disease - Pipeline by AriBio, 2021
Parkinson's Disease - Pipeline by ArmaGen Inc, 2021
Parkinson's Disease - Pipeline by Arrien Pharmaceuticals LLC, 2021
Parkinson's Disease - Pipeline by ArunA Biomedical Inc, 2021
Parkinson's Disease - Pipeline by Arvinas Inc, 2021
Parkinson's Disease - Pipeline by Asceneuron SA, 2021
Parkinson's Disease - Pipeline by Asdera LLC, 2021
Parkinson's Disease - Pipeline by Ashvattha Therapeutics LLC, 2021
Parkinson's Disease - Pipeline by Asklepios BioPharmaceutical Inc, 2021
Parkinson's Disease - Pipeline by Aspen Neuroscience Inc, 2021
Parkinson's Disease - Pipeline by Astellas Pharma Inc, 2021
Parkinson's Disease - Pipeline by AstraZeneca Plc, 2021
Parkinson's Disease - Pipeline by Caraway Therapeutics Inc, 2021
Parkinson's Disease - Pipeline by Carmot Therapeutics Inc, 2021
Parkinson's Disease - Pipeline by Carna Biosciences Inc, 2021
Parkinson's Disease - Pipeline by Casma Therapeutics Inc, 2021
Parkinson's Disease - Pipeline by CavoGene LifeSciences, 2021
Parkinson's Disease - Pipeline by Celavie Biosciences LLC, 2021
Parkinson's Disease - Pipeline by CellCure, 2021
Parkinson's Disease - Pipeline by Cellivery Therapeutics Inc, 2021
Parkinson's Disease - Pipeline by Cellix Bio Pvt Ltd, 2021
Parkinson's Disease - Pipeline by Celros Biotech Co Ltd, 2021
Parkinson's Disease - Pipeline by Cerecin Pte Ltd, 2021
Parkinson's Disease - Pipeline by CereSpir Inc, 2021
Parkinson's Disease - Pipeline by Coave Therapeutics, 2021
Parkinson's Disease - Pipeline by Cogentis Therapeutics Inc, 2021
Parkinson's Disease - Pipeline by Cognition Therapeutics Inc, 2021
Parkinson's Disease - Pipeline by Collaborative Medicinal Development LLC, 2021
Parkinson's Disease - Pipeline by Contera Pharma ApS, 2021
Parkinson's Disease - Pipeline by Convalesce Inc, 2021
Parkinson's Disease - Pipeline by Copernicus Therapeutics Inc, 2021
Parkinson's Disease - Pipeline by Corium Inc, 2021
Parkinson's Disease - Pipeline by Cortexyme Inc, 2021
Parkinson's Disease - Pipeline by Coya Therapeutics Inc, 2021
Parkinson's Disease - Pipeline by Fulcrum Therapeutics Inc, 2021
Parkinson's Disease - Pipeline by Gain Therapeutics Inc, 2021
Parkinson's Disease - Pipeline by GB Sciences Inc, 2021
Parkinson's Disease - Pipeline by Gene Therapy Research Institution Co Ltd, 2021
Parkinson's Disease - Pipeline by Generoath Co Ltd, 2021
Parkinson's Disease - Pipeline by Genervon Biopharmaceuticals LLC, 2021
Parkinson's Disease - Pipeline by GenKyoTex SA, 2021
Parkinson's Disease - Pipeline by Genmab AS, 2021
Parkinson's Disease - Pipeline by Gismo Therapeutics Inc, 2021
Parkinson's Disease - Pipeline by GL Pharm Tech Corp, 2021
Parkinson's Disease - Pipeline by Global BioLife Inc Ltd, 2021
Parkinson's Disease - Pipeline by GNT Pharma Co Ltd, 2021
Parkinson's Disease - Pipeline by GraySpace Therapeutics Inc, 2021
Parkinson's Disease - Pipeline by Grespo AB, 2021
Parkinson's Disease - Pipeline by Guangdong East Sunshine Pharmaceutical Co Ltd, 2021
Parkinson's Disease - Pipeline by Guangzhou DM Intelligence Ltd, 2021
Parkinson's Disease - Pipeline by Guangzhou Magpie Pharmaceutical Co Ltd, 2021
Parkinson's Disease - Pipeline by H. Lundbeck AS, 2021
Parkinson's Disease - Pipeline by Hangzhou Zede Pharmaceutical Technology Co Ltd, 2021
Parkinson's Disease - Pipeline by Hebei Newtherapy BIo-Pharma Technology Co Ltd, 2021
Parkinson's Disease - Pipeline by Help Therapeutics, 2021
Parkinson's Disease - Pipeline by Herantis Pharma Plc, 2021
Parkinson's Disease - Pipeline by Hillhurst Biopharmaceuticals Inc, 2021
Parkinson's Disease - Pipeline by Mitsubishi Tanabe Pharma Corp, 2021
Parkinson's Disease - Pipeline by Modag GmbH, 2021
Parkinson's Disease - Pipeline by Molomics Biotech SL, 2021
Parkinson's Disease - Pipeline by Montisera Ltd, 2021
Parkinson's Disease - Pipeline by Motac Neuroscience Ltd, 2021
Parkinson's Disease - Pipeline by Neonc Technologies Inc, 2021
Parkinson's Disease - Pipeline by Netherlands Translational Research Center BV, 2021
Parkinson's Disease - Pipeline by NeuExcell Therapeutics Inc, 2021
Parkinson's Disease - Pipeline by Neuracle Science Co Ltd, 2021
Parkinson's Disease - Pipeline by Neuraly Inc, 2021
Parkinson's Disease - Pipeline by Neuramedy Co Ltd, 2021
Parkinson's Disease - Pipeline by Neuren Pharmaceuticals Ltd, 2021
Parkinson's Disease - Pipeline by Neuro Vigor LLC, 2021
Parkinson's Disease - Pipeline by Neurocea Pharmaceuticals, 2021
Parkinson's Disease - Pipeline by Neurochlore, 2021
Parkinson's Disease - Pipeline by Neurodon LLC, 2021
Parkinson's Disease - Pipeline by Neuroene Therapeutics LLC, 2021
Parkinson's Disease - Pipeline by NeuroGeneration Inc, 2021
Parkinson's Disease - Pipeline by Neuron23 Inc, 2021
Parkinson's Disease - Pipeline by Neurona Therapeutics Inc, 2021
Parkinson's Disease - Pipeline by NeuroNascent Inc, 2021
Parkinson's Disease - Pipeline by NeuroPn Therapeutics LLC, 2021
Parkinson's Disease - Pipeline by Neuropore Therapies Inc, 2021
Parkinson's Disease - Pipeline by New Amsterdam Sciences Inc, 2021
Parkinson's Disease - Pipeline by New Biotic Inc, 2021
Parkinson's Disease - Pipeline by New World Laboratories Inc, 2021
Parkinson's Disease - Pipeline by Newron Pharmaceuticals SpA, 2021
Parkinson's Disease - Pipeline by Nexmos Inc, 2021
Parkinson's Disease - Pipeline by Nitrome Biosciences Inc, 2021
Parkinson's Disease - Pipeline by nLife Therapeutics SL, 2021
Parkinson's Disease - Pipeline by NLS Pharma Group, 2021
Parkinson's Disease - Pipeline by Novartis AG, 2021
Parkinson's Disease - Pipeline by Novo Nordisk AS, 2021
Parkinson's Disease - Pipeline by NRG Therapeutics Ltd, 2021
Parkinson's Disease - Pipeline by NTZ Lab Ltd, 2021
Parkinson's Disease - Pipeline by NutriBand Inc, 2021
Parkinson's Disease - Pipeline by Ohara Pharmaceutical Co Ltd, 2021
Parkinson's Disease - Pipeline by Omeros Corp, 2021
Parkinson's Disease - Pipeline by Oncodesign SA, 2021
Parkinson's Disease - Pipeline by Orphazyme A/S, 2021
Parkinson's Disease - Pipeline by Orpheris Inc, 2021
Parkinson's Disease - Pipeline by Oryzon Genomics SA, 2021
Parkinson's Disease - Pipeline by Oxyrane Belgium NV, 2021
Parkinson's Disease - Pipeline by Parkure Ltd, 2021
Parkinson's Disease - Pipeline by Peptron Inc, 2021
Parkinson's Disease - Pipeline by Pfizer Inc, 2021
Parkinson's Disease - Pipeline by Pharma Two B Ltd, 2021
Parkinson's Disease - Pipeline by PharmaTher Holdings Ltd, 2021
Parkinson's Disease - Pipeline by PharmatrophiX Inc, 2021
Parkinson's Disease - Pipeline by Phoenix Biotechnology Inc, 2021
Parkinson's Disease - Pipeline by Phoenix Life Sciences International Ltd, 2021
Parkinson's Disease - Pipeline by PK Biosciences Corp, 2021
Parkinson's Disease - Pipeline by Plex Pharmaceuticals Inc, 2021
Parkinson's Disease - Pipeline by Polaryx Therapeutics Inc, 2021
Parkinson's Disease - Pipeline by PolyCore Therapeutics LLC, 2021
Parkinson's Disease - Pipeline by Praxis Precision Medicines Inc, 2021
Parkinson's Disease - Pipeline by Priavoid GmbH, 2021
Parkinson's Disease - Pipeline by Prilenia Therapeutics Development Ltd, 2021
Parkinson's Disease - Pipeline by Vincere Biosciences Inc, 2021
Parkinson's Disease - Pipeline by Vivifi Biotech Ltd, 2021
Parkinson's Disease - Pipeline by Vivreon Biosciences LLC, 2021
Parkinson's Disease - Pipeline by Voyager Therapeutics Inc, 2021
Parkinson's Disease - Pipeline by Whan In Pharm Co Ltd, 2021
Parkinson's Disease - Pipeline by Wren Therapeutics Ltd, 2021
Parkinson's Disease - Pipeline by Xcelthera INC, 2021
Parkinson's Disease - Pipeline by Xoc Pharmaceuticals Inc, 2021
Parkinson's Disease - Pipeline by XYnapse Therapeutics Pty Ltd, 2021
Parkinson's Disease - Pipeline by Yuhan Corp, 2021
Parkinson's Disease - Pipeline by Yumanity Therapeutics Inc, 2021
Parkinson's Disease - Pipeline by Zhittya Genesis Medicine Inc, 2021
Parkinson's Disease - Dormant Projects, 2021
Parkinson's Disease - Discontinued Products, 2021
List of Figures
Number of Products under Development for Parkinson's Disease, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Top 10 Routes of Administration, 2021
Number of Products by Stage and Top 10 Routes of Administration, 2021
Number of Products by Top 10 Molecule Types, 2021
Number of Products by Stage and Top 10 Molecule Types, 2021

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook